Jamie Christensen, SVP, Chief Scientific Officer at Mirati Therapeutics, Inc. (MRTX), sold 19,649 shares at $49.43 ($965K) on 2018-06-27, disclosed to the SEC on 2018-06-28.
Open-market sale of $965k MRTX by SVP, Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.62 | 4,058 | $197K | 20.4% |
| 2 | $48.62 | 4,058 | $197K | 20.4% |
| 3 | $49.27 | 1,150 | $57K | 5.9% |
| 4 | $49.27 | 1,150 | $57K | 5.9% |
| 5 | $49.43 | 4,234 | $209K | 21.7% |
| 6 | $49.43 | 4,234 |
| $209K |
| 21.7% |
| 7 | $50.15 | 736 | $37K | 3.8% |
| 8 | $51.33 | 29 | $1K | 0.2% |
| Total | $49.11 avg | 19,649 | $965K | 100% |
| Filing → |
| MRTX | SELL | 2023-12-19 | $275K | — | Filing → |
| MRTX | SELL | 2023-09-12 | $170K | — | Filing → |
| MRTX | SELL | 2023-05-24 | $28K | — | Filing → |